JP2007307084A - Method for estimating whitening effect by measuring blood circulation - Google Patents

Method for estimating whitening effect by measuring blood circulation Download PDF

Info

Publication number
JP2007307084A
JP2007307084A JP2006138243A JP2006138243A JP2007307084A JP 2007307084 A JP2007307084 A JP 2007307084A JP 2006138243 A JP2006138243 A JP 2006138243A JP 2006138243 A JP2006138243 A JP 2006138243A JP 2007307084 A JP2007307084 A JP 2007307084A
Authority
JP
Japan
Prior art keywords
skin
whitening effect
amount
treatment
evaluation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006138243A
Other languages
Japanese (ja)
Other versions
JP5000196B2 (en
Inventor
Akihiro Munakata
明博 棟方
Yuji Masuda
勇二 舛田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shiseido Co Ltd
Original Assignee
Shiseido Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shiseido Co Ltd filed Critical Shiseido Co Ltd
Priority to JP2006138243A priority Critical patent/JP5000196B2/en
Publication of JP2007307084A publication Critical patent/JP2007307084A/en
Application granted granted Critical
Publication of JP5000196B2 publication Critical patent/JP5000196B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Measuring And Recording Apparatus For Diagnosis (AREA)

Abstract

<P>PROBLEM TO BE SOLVED: To provide a method for estimating whitening effect by measuring an increase in whiteness of the skin color due to a skin color change caused by promoted blood circulation. <P>SOLUTION: The method for estimating whitening effect comprises a step of measuring skin spectra by means of a colorimeter before and after being subjected to a whitening effect promoting treatment, a step of calculating an increase rate of average total-hemoglobin content of the skin region before and after the treatment on the basis of the measured skin spectra, and a step of determining whitening effect on the basis of the increase rate of average total-hemoglobin content. The whitening effect promoting treatment is performed on the forehead, under the eyes and the cheek. Whitening effect is determined to be effective when the increase rate of average total-hemoglobin content is ≥10% and ≤20%. <P>COPYRIGHT: (C)2008,JPO&INPIT

Description

本発明は、美白の評価方法に関し、より詳細には、血行状態を計測することによる肌の美白効果の評価方法に関する。   The present invention relates to a whitening evaluation method, and more particularly to a skin whitening effect evaluation method by measuring a blood circulation state.

従来から、一般的な色の計測は、光を入射させ、その光の反射率を出発データとして論理展開されており、JISにも規定されて、幅広い分野で利用されている。例えば、肌の色もこの技術で計測されているので、皮膚表面に特定波長の光を入射させ、その反射光を受光して特定波長における皮膚の反射率を求め、これにより色素沈着など皮膚中の黒褐色〜黒色の色素であるメラニンの多寡に注目して美白効果の評価が行なわれてきた。   Conventionally, in general color measurement, light is incident and the reflectance of the light is logically developed as starting data, which is defined in JIS and used in a wide range of fields. For example, skin color is also measured by this technique, so light of a specific wavelength is incident on the surface of the skin, and the reflected light is received to determine the reflectance of the skin at the specific wavelength. The whitening effect has been evaluated by paying attention to the amount of melanin, which is a black-brown to black pigment.

肌色測定においては、光の反射率を高めることが白くなるという光学的要件であり、肌が持つ光の吸収体としての色素、例えば、メラニン色素は少ないことが条件となる。このことから、多くの美白化粧品は、メラニン色素の減少と、それに伴う肌の明度の増加、つまり、L表色系の場合はL値(白さ)の増加を美白効果の拠り所としており、それらの美白化粧品を使用した際の美白効果の評価においても、減少されるメラニン色素の減少によって光の反射率が高められ、増大した肌の明度、すなわちL値(白さ)を判断基準として用いてきた。 In the skin color measurement, it is an optical requirement that whiteness increases the reflectance of light, and the condition is that there are few pigments, for example, melanin pigments, as light absorbers of the skin. Therefore, many of whitening cosmetics, a decrease of melanin, increasing the brightness of the skin associated therewith, i.e., L * a * b * in the case of the color system L * value increased whitening effect of (whiteness) In the evaluation of the whitening effect when these whitening cosmetics are used, the reflectance of light is enhanced by the decrease in the decreased melanin pigment, and the increased skin lightness, that is, the L * value (whiteness ) Has been used as a criterion.

しかしながら、現在の色彩科学の技術は完全ではなく、視覚における感覚的な「見え」と必ずしも合致しないケースが報告されており、感覚的な「見え」が有効な評価基準として考慮される場合もある。特に、肌の測色では単なる光の反射と吸収から色彩が決定されるので、肌の「見え」の要素は正確に反映されていない問題があった。   However, current color science technology is not perfect, and cases have been reported that do not necessarily match the sensory “appearance” in vision, and sensory “appearance” may be considered as an effective evaluation criterion. . In particular, since the color is determined by simple reflection and absorption of light in skin color measurement, there is a problem that the element of “appearance” of the skin is not accurately reflected.

また、肌色に寄与する成分として、メラニン色素だけでなく、ヘモグロビン成分も挙げられており、皮膚の表面状態との関連性も研究されている。
特開平10−127585号公報 特開2005−34355号公報 特開2003−275179号公報 特開2002−200050号公報 特開2004−283357号公報 特開2004−216011号公報
In addition to melanin pigments, hemoglobin components are listed as components that contribute to the skin color, and the relationship with the surface condition of the skin has been studied.
Japanese Patent Laid-Open No. 10-127585 JP 2005-34355 A JP 2003-275179 A JP 2002-200050 A JP 2004-283357 A JP 2004-216011 A

したがって、本発明は、上述に鑑みてなされたものであり、血行促進による肌色変化がもたらす肌色の白さ感の上昇を美白効果の評価に適用する方法を提供することを目的とする。   Therefore, the present invention has been made in view of the above, and an object of the present invention is to provide a method of applying an increase in the whiteness of the skin color caused by the skin color change caused by blood circulation promotion to the evaluation of the whitening effect.

本発明者らは、通常の肌色計測に加え、肌のメラニン量とヘモグロビン量を算出し、ヘモグロビン量の変化と肌色の見え方の関係を解析して、ヘモグロビンの増加が見た目の白さを増加させることを見出し、本発明を開発するに到った。   In addition to normal skin color measurement, the inventors calculated the amount of melanin and hemoglobin in the skin, analyzed the relationship between the change in the amount of hemoglobin and the appearance of the skin color, and the increase in hemoglobin increased the whiteness of appearance. As a result, the present invention has been developed.

すなわち、請求項1記載の発明は、美白効果を高める処理を行なった皮膚に対し、該処理前後で測色機によって皮膚スペクトルを計測するステップと、該皮膚スペクトル計測により、該皮膚部位の処理前後での平均総ヘモグロビン含有量の増加率を算出するステップと、該平均総ヘモグロビン含有量の増加率により美白効果を判断するステップとを有する美白効果を評価する方法によって達成される。   That is, the invention according to claim 1 includes a step of measuring a skin spectrum with a colorimeter before and after the treatment on the skin subjected to the treatment for enhancing the whitening effect, and before and after the treatment of the skin site by the skin spectrum measurement. And calculating the whitening effect based on the increase rate of the average total hemoglobin content and determining the whitening effect based on the increase rate of the average total hemoglobin content.

上記発明によれば、例えば、美白剤を適用したり、美容マッサージを施した肌に対して、測色機によって皮膚スペクトルを解析して、計測部位の平均総ヘモグロビン含有量の増加率を判断することによって美白効果を評価できる。   According to the above invention, for example, the skin spectrum is analyzed by a colorimeter with respect to the skin to which a whitening agent is applied or a cosmetic massage is performed, and the increase rate of the average total hemoglobin content in the measurement site is determined. The whitening effect can be evaluated.

また、請求項2記載の発明は、請求項1記載の方法において、前記美白効果を高める処理を行なった皮膚は、額、目の下及び頬であることを特徴とする。   The invention described in claim 2 is characterized in that, in the method described in claim 1, the skin subjected to the treatment for enhancing the whitening effect is a forehead, a lower part of the eyes, and a cheek.

上記発明によれば、例えば、美白剤を適用したり、美容マッサージを施す、額、目の下及び頬に対して、測色機によって皮膚スペクトルを解析して、計測部位の平均総ヘモグロビン含有量の増加率を判断することによって美白効果を評価できる。   According to the above-mentioned invention, for example, applying a whitening agent or applying a beauty massage, forehead, under the eyes and cheeks, the skin spectrum is analyzed by a colorimeter, and the average total hemoglobin content of the measurement site is increased. The whitening effect can be evaluated by judging the rate.

また、請求項3記載の発明は、請求項2記載の方法において、前記平均総ヘモグロビン含有量の増加率は、10%以上20%以下であることを特徴とする。   The invention according to claim 3 is characterized in that, in the method according to claim 2, the increasing rate of the average total hemoglobin content is 10% or more and 20% or less.

上記発明によれば、例えば、美白剤を適用したり、美容マッサージを施した肌に対して、測色機によって皮膚スペクトルを解析して、計測部位の平均総ヘモグロビン含有量の増加率が10%以上20%以下である場合、有効な美白効果として評価できる。   According to the above invention, for example, the skin spectrum is analyzed by a colorimeter with respect to skin to which a whitening agent is applied or cosmetic massage is performed, and the increase rate of the average total hemoglobin content in the measurement site is 10%. When it is 20% or less, it can be evaluated as an effective whitening effect.

本発明によれば、美白効果の評価基準として、肌が持つ光の吸収体としてのメラニン色素の減少と、それに伴うL表色系のL値(白さ)の増加に依存することなく、血行促進による肌色変化がもたらす肌色の白さ感の上昇を美白効果の評価に適用することができる。つまり、肌色の白さ感の高まりを評価する際に、皮膚スペクトルの解析によって、額、目の下、頬の3部位における血中の平均総ヘモグロビン増加率が10%以上20%以下である場合に、良好な美白効果を達成できたものとして評価できる。 According to the present invention, as an evaluation standard for the whitening effect, the decrease in melanin as a light absorber of the skin and the accompanying increase in the L * value (whiteness) of the L * a * b * color system The increase in the whiteness of the skin color caused by the skin color change due to blood circulation promotion can be applied to the evaluation of the whitening effect without depending on the blood circulation. That is, when evaluating the increase in the whiteness of the skin color, when the average total hemoglobin increase rate in the blood in the three parts of the forehead, under the eyes, and cheeks is 10% or more and 20% or less by analyzing the skin spectrum, It can be evaluated as having achieved a good whitening effect.

以下に添付図を参照しながら本発明を詳細に説明する。   Hereinafter, the present invention will be described in detail with reference to the accompanying drawings.

本発明の美白効果の評価方法は、血行が改善した肌は健康的で白く好ましい肌色に見えるという仮説の下に、ヘモグロビン量の変化と肌色の見えに着目した研究を行い、適度に血行が改善した肌では色彩学的な測定上の肌色は黒く(L表色系でLは低く)計測されるが感覚的な見えとしての肌色は白く感じることを導き出し、新たな美白効果の評価方法として、通常の肌色計測でヘモグロビン量を算出し、ヘモグロビン量の変化と肌色の見え方の関係を解析することによる、新規な美白効果の評価を特徴とする。なお、L表色系では、L値は明度(白黒)を示し、値が小さいほど暗く(黒い)、値が大きいほど明るい(白い)、a値とb値で色相・彩度を表し、肌色が属する色領域である第一象限でaは赤み、bは黄みを示す。 The method of evaluating the whitening effect of the present invention is based on the hypothesis that the skin with improved blood circulation looks healthy and white and has a favorable skin color. The skin color on chromatic measurement is black (L * a * b * color system, L * is low), but the skin color as a sensuous appearance is derived white, leading to a new whitening As an effect evaluation method, the present invention is characterized by a novel whitening effect evaluation by calculating the amount of hemoglobin by normal skin color measurement and analyzing the relationship between the change in the amount of hemoglobin and the appearance of the skin color. In the L * a * b * color system, the L * value indicates lightness (black and white). The smaller the value, the darker (black), the larger the value, the brighter (white), and the a * value and b * value. In the first quadrant, which is the color region to which the skin color belongs, a * indicates redness and b * indicates yellowness.

したがって、本発明の好ましい態様では、美白効果を高める処理を行なった皮膚に対し、処理前後で測色機によって皮膚スペクトルを計測するステップと、皮膚スペクトル計測により、皮膚部位の処理前後での平均総ヘモグロビン含有量の増加率を算出するステップと、平均総ヘモグロビン含有量の増加率により美白効果を判断するステップとによって、肌の美白効果を評価する。より詳細には、額、目の下、頬の3部位を市販の測色機(コニカ・ミノルタCM2600d)にて皮膚スペクトルを計測(特願平10−106517号公報)して、さらにそれら3部位における血中の酸化型ヘモグロビン量と還元型ヘモグロビン量を測定して、その和である総ヘモグロビン量を算出し、その平均総ヘモグロビン量の増加率によって、美白効果を評価することを特徴とする。   Therefore, in a preferred embodiment of the present invention, a step of measuring the skin spectrum with a colorimeter before and after the treatment on the skin subjected to the treatment for enhancing the whitening effect, and an average total before and after the treatment of the skin part by the skin spectrum measurement. The skin whitening effect is evaluated by calculating the increase rate of the hemoglobin content and determining the whitening effect based on the increase rate of the average total hemoglobin content. More specifically, the skin spectrum of the three parts of the forehead, under the eyes, and cheeks is measured with a commercially available colorimeter (Konica Minolta CM2600d) (Japanese Patent Application No. 10-106517), and blood in those three parts is further measured. The amount of oxidized hemoglobin and the amount of reduced hemoglobin are measured, the total hemoglobin amount is calculated as the sum, and the whitening effect is evaluated by the increase rate of the average total hemoglobin amount.

このように、本発明によれば、額、目の下、頬の3部位における血中の平均総ヘモグロビン量を求めることができ、血中の平均総ヘモグロビン量の増加率が10%以上20%以下の場合に良好な美白効果となる。当該部位の血中の平均総ヘモグロビン量の増加率が10%よりも低い場合、皮膚スペクトル解析による明度値からも、視覚的な肌の見えにおいても明らかに肌色の白さ感はなく、当該部位の血中の平均総ヘモグロビン量の増加率が20%を超える場合、赤味を帯びた赤ら顔となり、美白効果の判断が困難になる。   Thus, according to the present invention, it is possible to determine the average total hemoglobin amount in the blood at the three parts of the forehead, under the eyes, and cheeks, and the increase rate of the average total hemoglobin amount in the blood is 10% or more and 20% or less. In some cases, the whitening effect is good. When the increase rate of the average total hemoglobin amount in the blood of the part is lower than 10%, there is no whiteness of the skin color clearly from the lightness value by the skin spectrum analysis or the visual appearance of the skin. When the increase rate of the average total hemoglobin in the blood exceeds 20%, the face becomes reddish and the whitening effect is difficult to judge.

以下、実施例によって、本発明を詳細に説明する。   Hereinafter, the present invention will be described in detail by way of examples.

下記に、本発明を詳細に説明するが、本発明はこれらによって制限されるものではない。   The present invention is described in detail below, but the present invention is not limited thereto.

図1は、シミそばかすの気になる被験者(女性30人)に対して、3ヵ月にわたって美白剤(資生堂ホワイトルーセントセラムエクセレント:株式会社資生堂)を連用し、連用前と連用後での皮膚計測(コニカ・ミノルタ社CM2600d)における肌色測色値(L)、メラニン・ヘモグロビン量を示す図である。被験者本人の自己評価と専門美容技術者の評価による官能評価によって、肌色に関して5段階評価(1:黒くなった、2:やや黒くなった、3:変化なし、4:やや白くなった、5:白くなった)を行ない、効果あり(4:やや白くなった、5:白くなった)と判定された群、効果なし(1:黒くなった、2:やや黒くなった、3:変化なし)と判定された群を、図中の各グラフにおいて、それぞれ、右と左に示した。なお、肌色の効果あり群は、被験者30人のうち、20人である。同図に示すように、美白効果が認められた群において、一般的に、肌の明るさの指標となるL値は美白効果とは関連しておらず、一方で、メラニン量の減少に加えて、血中のヘモグロビン量、特に、酸化型ヘモグロビン量の増加が認められる。 Fig. 1 shows skin measurements before and after continuous use of a whitening agent (Shiseido White Lucent Serum Excellent: Shiseido Co., Ltd.) for 3 months for subjects who are worried about freckles (30 women). It is a figure which shows the skin color measurement value (L * a * b * ) and the amount of melanin and hemoglobin in Konica Minolta CM2600d). Based on the subject's self-evaluation and sensory evaluation based on the evaluation of a professional beauty technician, the skin color was evaluated in five levels (1: blackened, 2: slightly blackened, 3: no change, 4: slightly whitened, 5: Group that was judged to be effective (4: slightly whitened, 5: whitened), no effect (1: blackened, 2: slightly blackened, 3: no change) The groups determined as are shown on the right and left in each graph in the figure. In addition, the group with the effect of skin color is 20 out of 30 subjects. As shown in the figure, in the group in which the whitening effect was recognized, the L * value that is an index of skin brightness is generally not related to the whitening effect, while the decrease in the amount of melanin. In addition, an increase in the amount of hemoglobin in the blood, in particular, the amount of oxidized hemoglobin is observed.

そこで、美白剤の連用前と3ヵ月の連用後において、1)メラニン量のみが減少したパネル、2)ヘモグロビン量のみが増加したパネル、3)メラニン量が減少し、ヘモグロビン量が増加したパネルのデジタル顔画像と被験者本人の自己評価による肌色の官能評価をそれぞれ図2乃至4に示す。これらの図から、肌色変化は、1)が変化なし、2)ではやや白くなり、3)では白くなったことが確認された。   Therefore, before the continuous use of the whitening agent and after continuous use for 3 months, 1) a panel in which only the amount of melanin decreased, 2) a panel in which only the amount of hemoglobin increased, and 3) a panel in which the amount of melanin decreased and the amount of hemoglobin increased. Sensory evaluation of the skin color by the digital face image and the subject's own self-evaluation is shown in FIGS. From these figures, it was confirmed that the skin color change was 1) no change, 2) slightly white, and 3) white.

したがって、被験者本人の自己評価による肌色の官能評価によって美白効果を感じる場合、メラニン量の減少に加えて、酸化ヘモグロビン量の増加が認識された。このことから、肌色の白さ感を高めるためには、美白剤によるメラニン生成抑制に加えて、血行促進による肌色変化が美白効果として有効であることが分かる。つまり、換言すると、肌の血行状態を計測することによって、美白効果を評価することができる。   Therefore, in the case where the whitening effect was felt by the skin color sensory evaluation based on the self-evaluation of the subject himself, an increase in the amount of oxyhemoglobin was recognized in addition to the decrease in the amount of melanin. From this, it can be seen that, in order to enhance the whiteness of the skin color, in addition to the suppression of melanin production by the whitening agent, the skin color change by promoting blood circulation is effective as a whitening effect. In other words, the whitening effect can be evaluated by measuring the blood circulation state of the skin.

血流増加の肌改善が美白効果感に及ぼす影響を確認した。   The effect of skin improvement with increased blood flow on the whitening effect was confirmed.

本実施例では、一般的に行なわれている、例えば、顔と首の皮膚や筋肉に対して、さする・揉む・押す・たたくなどの汎用的なマッサージなどの顔面マッサージと収斂化粧水(資生堂エリクシールコンディショニングウォーター)との施術による血流改善によって、血色の良い健康的な肌状態としたときの肌色の見えとシワの目立ち感を5名のパネルにおいて実験で確認した。   In this embodiment, for example, facial massage such as general massage such as touch, massage, push, and tap on the skin and muscles of the face and neck and astringent lotion (Shiseido) By the improvement of blood flow by treatment with Elixir Conditioning Water), the skin color appearance and wrinkle conspicuousness when the skin color was good and healthy were confirmed by experiments on five panels.

施術前後の肌において、パネル本人の自己評価と専門技術者による視感評価を行ない、施術前後肌に測色機ヘッドを密着させて皮膚スペクトル(肌色、メラニン量、ヘモグロビン量)を計測し、通常の写真撮影に準じた方法でサーモグラフィーによる皮膚表面温度を計測し、さらにデジタル顔写真によって、評価を行なった。   The skin before and after the treatment is self-evaluated by the panel and a visual engineer evaluates the skin, and the skin spectrum (skin color, melanin amount, hemoglobin amount) is measured by attaching the colorimeter head to the skin before and after the treatment. The skin surface temperature by thermography was measured by a method according to the above-mentioned photography, and further evaluated by digital face photography.

図5に、パネル本人の自己評価と専門技術者による視感評価の項目と評価尺度の段階を示した。   FIG. 5 shows the items of the self-evaluation of the panel himself and the visual evaluation by the professional engineer and the stage of the evaluation scale.

図6に、5名のパネルに対する顔面マッサージと収斂化粧水による施術前後のメラニン量と酸化ヘモグロビン量の変化を示す。図6から明らかなように、顔面マッサージと収斂化粧水による施術によって、メラニン量に変化は見られなかったが、酸化ヘモグロビン量には有意な増加が認められ、血行促進効果が確認された。   FIG. 6 shows changes in the amount of melanin and the amount of oxyhemoglobin before and after treatment with facial massage and astringent lotion for a panel of five people. As is clear from FIG. 6, no change was observed in the amount of melanin by facial massage and astringent lotion, but a significant increase was observed in the amount of oxyhemoglobin, confirming the effect of promoting blood circulation.

また、図7に、専門技術者の視感評価による顔面マッサージと収斂化粧水による5名のパネルの平均肌状態変化を示す。専門技術者の視感評価では、血行促進効果は、肌の血行改善効果とつや改善効果として認識され、肌の明るさ、透明感、毛穴抑制として若干の効果として認識された。また、図8に、パネル本人が自己評価した顔面マッサージと収斂化粧水による平均肌状態変化を示す。この場合も、血行促進効果は、肌の明るさ、透明感、毛穴、くま等の様々な肌効果実感として認識された。   Moreover, the average skin state change of the panel of five by facial massage and astringent lotion by the expert's visual evaluation is shown in FIG. According to the visual evaluation of a professional engineer, the blood circulation promotion effect was recognized as a skin blood circulation improvement effect and a gloss improvement effect, and was recognized as a slight effect as skin brightness, transparency, and pore suppression. Moreover, the average skin state change by the facial massage and the astringent lotion which the panel person self-evaluated in FIG. 8 is shown. Also in this case, the blood circulation promoting effect was recognized as various skin effects such as skin brightness, transparency, pores, and bears.

また、図9には、視感評価によって、肌の白さと肌の明るさにおいて、顕著な改善を確認し、皮膚スペクトルにより、酸化ヘモグロビンの増加が認識され、サーモグラフィーで皮膚表面温度が増加した1名のパネルの施術前と後のデジタル顔画像を比較した施術効果を示す。   In addition, in FIG. 9, by visual evaluation, a remarkable improvement was confirmed in skin whiteness and skin brightness, and an increase in oxygenated hemoglobin was recognized by the skin spectrum, and the skin surface temperature increased by thermography. The effect of the treatment comparing the digital face images before and after the treatment of the name panel is shown.

よって、顔面マッサージと収斂化粧水による施術により血行促進効果が確認され、美白効果においては、血行促進が有効であることを確認した。また、血行促進により、美白効果だけでなく、透明感、毛穴、くまなどの肌改善効果が認められた。   Therefore, the blood circulation promotion effect was confirmed by the treatment with the facial massage and the astringent lotion, and it was confirmed that the blood circulation promotion was effective in the whitening effect. Moreover, not only the whitening effect but also skin improvement effects such as transparency, pores, and bears were recognized by promoting blood circulation.

したがって、美白剤を用いた場合には、メラニン量の低減に加えて、ヘモグロビン量の増加による血行促進によって美白効果が確認され、顔面マッサージと収斂化粧水による施術を用いた場合には、メラニン量の変化はないが、ヘモグロビン量の増加による血行促進によって顕著な美白効果が確認されるとともに、様々な肌改善効果が確認された。   Therefore, when using a whitening agent, in addition to reducing the amount of melanin, a whitening effect is confirmed by promoting blood circulation by increasing the amount of hemoglobin, and when using facial massage and astringent lotion, Although there was no change, a remarkable whitening effect was confirmed by promoting blood circulation by increasing the amount of hemoglobin, and various skin improvement effects were confirmed.

また、上記で顔面マッサージと収斂化粧水による施術を行なった5名のパネルにおいて、施術前後のパネル本人の自己評価と専門技術者2名による視感評価と、それらの結果から導かれる総合的な官能評価の結果を表1に示した。なお、表1における施術前後のパネル本人の自己評価と専門技術者2名による視感評価の項目と評価尺度の段階は、図5に示す評価項目と評価尺度の段階とは異なる。官能評価はパネル本人の自己評価は加味せず、専門技術者2名による視感評価から導き出された施術後数値から施術前数値を引いた差の値にマイナス数値がなければ○を、マイナス数値が一つあれば△を、マイナス数値が2つ以上あれば×とした。   In addition, in the panel of 5 people who performed the treatment with facial massage and astringent lotion as described above, the panel itself self-evaluation before and after the treatment and the visual evaluation by 2 professional engineers, and the comprehensive results derived from those results The results of sensory evaluation are shown in Table 1. Note that the items of the self-evaluation of the panel person before and after the treatment in Table 1 and the visual evaluation items by the two specialists and the stage of the evaluation scale are different from the evaluation items and the stage of the evaluation scale shown in FIG. The sensory evaluation does not take into account the panel's self-assessment. If there is no negative value in the difference between the postoperative value derived from the visual evaluation by two specialist engineers and the preoperative value, a negative value If there is one, △ is indicated, and if there are two or more negative values, it is indicated as x.

また、施術後の各5名のパネルにおいて、額、目の下、頬ごとに、それぞれメラニン、血中の酸化型ヘモグロビン、還元型ヘモグロビン、総ヘモグロビン量の施術前数値に対する施術後数値の増加率を変化率とした結果を表2に示す。 In addition, in each panel of 5 patients after the treatment, the rate of increase of the post-treatment value with respect to the pre-treatment value of melanin, oxidized hemoglobin in the blood, reduced hemoglobin, and total hemoglobin amount changed for each forehead, under the eyes and cheeks. The results are shown in Table 2.

さらに、各パネルごと、表2の結果の額、目の下、頬の平均の血中の酸化型ヘモグロビン、還元型ヘモグロビン、総ヘモグロビン量の変化率を表3に示す。 Further, for each panel, the amount of change in the amount of oxidized hemoglobin, reduced hemoglobin, and total hemoglobin in the average blood of the results in Table 2 and under the eyes and cheeks is shown in Table 3.

この結果から、額、目の下、頬の3部位の平均総ヘモグロビン量の変化率が10%以上のパネルにおいては、表1の官能評価でも美白効果に対して、良好な結果が得られた。図12に、表3によるパネル1乃至5の額、目の下、頬の3部位の平均総ヘモグロビン量の変化率と表1による官能総合判定との関係を示す。 From this result, in the panel in which the change rate of the average total hemoglobin amount at the three parts of the forehead, under the eyes, and cheeks was 10% or more, good results were obtained for the whitening effect even in the sensory evaluation of Table 1. FIG. 12 shows the relationship between the rate of change in the average total hemoglobin amount at the forehead of the panels 1 to 5 according to Table 3, the three parts of the lower part of the eye, and the cheek, and the sensory comprehensive determination according to Table 1.

また、比較例として、図10、11に額、目の下、頬の3部位の平均総ヘモグロビン量の変化率がそれぞれ22.3%、43.2%のデジタル顔写真を示すが、これらの図から分かるように、額、目の下、頬の3部位の平均総ヘモグロビン量の変化率が20%を超えると、赤味を帯びた赤ら顔となり、血行促進による美白効果の判断が困難になる。   As comparative examples, FIGS. 10 and 11 show digital face photographs in which the change rates of the average total hemoglobin amount at the three parts of the forehead, under the eyes, and cheeks are 22.3% and 43.2%, respectively. As can be seen, when the rate of change in the average total hemoglobin amount at the three parts of the forehead, under the eyes, and cheeks exceeds 20%, the face becomes reddish and the whitening effect by promoting blood circulation becomes difficult.

したがって、額、目の下、頬の3部位の平均総ヘモグロビン量の変化率が10%以上20%以下の場合に、良好な美白効果が認められた。   Therefore, a good whitening effect was observed when the change rate of the average total hemoglobin amount at the three parts of the forehead, under the eyes, and cheeks was 10% or more and 20% or less.

これらの結果から、美白効果の評価基準として、肌が持つ光の吸収体としてのメラニン色素の減少と、それに伴うL表色系のL(白さ)の増加に依存することなく、血行促進による肌色変化がもたらす肌色の白さ感の上昇を美白効果の評価に適用することができる。 From these results, the evaluation standard of the whitening effect depends on the decrease of melanin as a light absorber of skin and the accompanying increase in L * (whiteness) of L * a * b * color system. The increase in the whiteness of the skin color caused by the skin color change due to blood circulation promotion can be applied to the evaluation of the whitening effect.

したがって、本発明の美白効果の評価方法は、血行促進による有効性を加味したものであり、肌の白さ感を測定する部位の血中のヘモグロビン量の変化を測定することで肌の白さ感の高まりを評価することができる。   Therefore, the method for evaluating the whitening effect of the present invention takes into account the effectiveness of promoting blood circulation, and the whiteness of the skin is measured by measuring the change in the amount of hemoglobin in the blood at the site where the whiteness of the skin is measured. The increase in feeling can be evaluated.

以上本発明の好ましい実施例について詳述したが、本発明はかかる特定の実施形態に限定されるものではなく、特許請求の範囲に記載された本発明の要旨の範囲内において、種々の変形・変更が可能である。   The preferred embodiments of the present invention have been described in detail above, but the present invention is not limited to such specific embodiments, and various modifications and changes can be made within the scope of the gist of the present invention described in the claims. It can be changed.

シミそばかすの気になる被験者に対して、3ヵ月にわたって美白剤を連用し、連用前と連用後での皮膚計測における肌色測色値(L)、メラニン・ヘモグロビン量を示す図である。Figure showing skin colorimetric values (L * a * b * ) and melanin / hemoglobin levels in skin measurements before and after continuous use of a whitening agent over a period of 3 months for subjects concerned with freckles It is. 美白剤の連用前と3ヵ月の連用後において、1)メラニン量のみが減少したパネルのデジタル顔画像と被験者本人の自己評価による肌色の官能評価を示す図である。It is a figure which shows the sensory evaluation of the skin color by 1) the digital face image of the panel in which only the amount of melanin decreased, and the subject's own self-evaluation before continuous use of the whitening agent and after continuous use for 3 months. 美白剤の連用前と3ヵ月の連用後において、2)ヘモグロビン量のみが増加したパネルのデジタル顔画像と被験者本人の自己評価による肌色の官能評価を示す図である。It is a figure which shows the sensory evaluation of the skin color by 2) the digital face image of the panel in which only the amount of hemoglobin increased, and the test subject's own self-evaluation before continuous use of a whitening agent, and after continuous use for 3 months. 美白剤の連用前と3ヵ月の連用後において、3)メラニン量が減少し、ヘモグロビン量が増加したパネルのデジタル顔画像と被験者本人の自己評価による肌色の官能評価を示す図である。It is a figure which shows the sensory evaluation of the skin color by the digital face image of the panel where the amount of melanin decreased and the amount of hemoglobin increased, and the subject's own self-evaluation before continuous use of the whitening agent and after continuous use for 3 months. パネル本人の自己評価と専門技術者による視感評価の項目と評価尺度の段階を示す図である。It is a figure which shows the stage of the self-evaluation of a panel person, the item of visual evaluation by a professional engineer, and an evaluation scale. 顔面マッサージと収斂化粧水による施術前後のメラニン量と酸化ヘモグロビン量の変化を示す図である。It is a figure which shows the change of the melanin amount before and behind the treatment by a facial massage and an astringent lotion, and the amount of oxyhemoglobin. 専門技術者の視感評価による顔面マッサージと収斂化粧水による5名のパネルの平均肌状態変化を示す図である。It is a figure which shows the average skin state change of five panels by the facial massage and astringent lotion by the visual evaluation of a professional engineer. パネル本人が自己評価した顔面マッサージと収斂化粧水による平均肌状態変化を示す図である。It is a figure which shows the average skin state change by the facial massage and the astringent lotion self-evaluated by the panel person. 視感評価によって、肌の白さと肌の明るさにおいて、顕著な改善を確認し、皮膚スペクトルにより、酸化ヘモグロビンの増加が認識され、サーモグラフィーで皮膚表面温度が増加した1名のパネルの施術前と後のデジタル顔画像を比較した施術効果の一例を示す図である。Visual evaluation confirmed a marked improvement in skin whiteness and skin brightness, skin spectrum showed an increase in oxyhemoglobin, and thermography increased skin surface temperature before treatment for one panel. It is a figure which shows an example of the treatment effect which compared the digital face image after. 額、目の下、頬の3部位の平均総ヘモグロビン量の変化率が20%を超えた顔写真である。It is a face photograph in which the change rate of the average total hemoglobin amount in the three parts of the forehead, under the eyes, and cheeks exceeds 20%. 額、目の下、頬の3部位の平均総ヘモグロビン量の変化率が20%を超えた顔写真である。It is a face photograph in which the change rate of the average total hemoglobin amount in the three parts of the forehead, under the eyes, and cheeks exceeds 20%. 表3によるパネル1乃至5の額、目の下、頬の3部位の平均総ヘモグロビン量の変化率と表1による官能総合判定との関係を示す図である。FIG. 5 is a diagram showing the relationship between the change rate of the average total hemoglobin amount at the three foreheads of the panels 1 to 5 according to Table 3 and under the eyes and cheeks and the sensory comprehensive determination according to Table 1.

Claims (3)

美白効果を高める処理を行なった皮膚に対し、該処理前後で測色機によって皮膚スペクトルを計測するステップと、
該皮膚スペクトル計測により、該皮膚部位の処理前後での平均総ヘモグロビン含有量の増加率を算出するステップと、
該平均総ヘモグロビン含有量の増加率により美白効果を判断するステップと
を有する美白効果を評価する方法。
Measuring the skin spectrum with a colorimeter before and after the treatment on the skin subjected to the treatment for enhancing the whitening effect;
Calculating the rate of increase in average total hemoglobin content before and after treatment of the skin site by the skin spectrum measurement;
A method of evaluating a whitening effect, comprising: determining a whitening effect based on an increase rate of the average total hemoglobin content.
前記美白効果を高める処理を行なった皮膚は、額、目の下及び頬であることを特徴とする請求項1に記載の方法。   The method according to claim 1, wherein the skin subjected to the treatment for enhancing the whitening effect is a forehead, an eye and a cheek. 前記平均総ヘモグロビン含有量の増加率は、10%以上20%以下であることを特徴とする請求項1または2に記載の方法。   The method according to claim 1 or 2, wherein an increase rate of the average total hemoglobin content is 10% or more and 20% or less.
JP2006138243A 2006-05-17 2006-05-17 Evaluation method of whitening effect Active JP5000196B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2006138243A JP5000196B2 (en) 2006-05-17 2006-05-17 Evaluation method of whitening effect

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2006138243A JP5000196B2 (en) 2006-05-17 2006-05-17 Evaluation method of whitening effect

Publications (2)

Publication Number Publication Date
JP2007307084A true JP2007307084A (en) 2007-11-29
JP5000196B2 JP5000196B2 (en) 2012-08-15

Family

ID=38840492

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006138243A Active JP5000196B2 (en) 2006-05-17 2006-05-17 Evaluation method of whitening effect

Country Status (1)

Country Link
JP (1) JP5000196B2 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014002255A1 (en) * 2012-06-29 2014-01-03 株式会社 東芝 Health management support device, method and program
JP2014176047A (en) * 2013-03-13 2014-09-22 Fujifilm Corp Visual effect evaluation device, method and program, and image forming apparatus
WO2014204007A1 (en) 2013-06-19 2014-12-24 L'oreal Method for evaluating cosmetic effects of cosmetic product on skin
JP2019168292A (en) * 2018-03-22 2019-10-03 株式会社 資生堂 Method of evaluating risk of worsening skin color using leptin as indicator

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10127585A (en) * 1996-10-25 1998-05-19 Kao Corp Measuring method and device of optical properties of surface condition of skin
JP2000350702A (en) * 1999-06-14 2000-12-19 Shiseido Co Ltd Measurement method and apparatus for cutaneous constituents and characteristics
JP2004073327A (en) * 2002-08-12 2004-03-11 Naris Cosmetics Co Ltd Colorimetric method for skin, inorganic powder composition effective to remove darkness of skin, and cosmetic material using the same
JP2004216011A (en) * 2003-01-17 2004-08-05 Pola Chem Ind Inc Explanation display of aesthetic treatment method
JP2005034355A (en) * 2003-07-14 2005-02-10 Kao Corp Image processing apparatus and face image processing apparatus

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10127585A (en) * 1996-10-25 1998-05-19 Kao Corp Measuring method and device of optical properties of surface condition of skin
JP2000350702A (en) * 1999-06-14 2000-12-19 Shiseido Co Ltd Measurement method and apparatus for cutaneous constituents and characteristics
JP2004073327A (en) * 2002-08-12 2004-03-11 Naris Cosmetics Co Ltd Colorimetric method for skin, inorganic powder composition effective to remove darkness of skin, and cosmetic material using the same
JP2004216011A (en) * 2003-01-17 2004-08-05 Pola Chem Ind Inc Explanation display of aesthetic treatment method
JP2005034355A (en) * 2003-07-14 2005-02-10 Kao Corp Image processing apparatus and face image processing apparatus

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014002255A1 (en) * 2012-06-29 2014-01-03 株式会社 東芝 Health management support device, method and program
CN104411231A (en) * 2012-06-29 2015-03-11 株式会社东芝 Health management support device, method and program
JPWO2014002255A1 (en) * 2012-06-29 2016-05-30 株式会社東芝 Health care support device, method and program
JP2014176047A (en) * 2013-03-13 2014-09-22 Fujifilm Corp Visual effect evaluation device, method and program, and image forming apparatus
WO2014204007A1 (en) 2013-06-19 2014-12-24 L'oreal Method for evaluating cosmetic effects of cosmetic product on skin
JP2019168292A (en) * 2018-03-22 2019-10-03 株式会社 資生堂 Method of evaluating risk of worsening skin color using leptin as indicator
JP7214356B2 (en) 2018-03-22 2023-01-30 株式会社 資生堂 Skin color deterioration risk evaluation method using leptin as an index

Also Published As

Publication number Publication date
JP5000196B2 (en) 2012-08-15

Similar Documents

Publication Publication Date Title
Voegeli et al. Facial skin mapping: from single point bio‐instrumental evaluation to continuous visualization of skin hydration, barrier function, skin surface pH, and sebum in different ethnic skin types
JP6214914B2 (en) Skin dullness evaluation apparatus, skin dullness evaluation method, and skin dullness evaluation program
JP5797921B2 (en) Body surface evaluation method and body surface evaluation apparatus
JP4842424B2 (en) Method for measuring and evaluating skin texture, and use of a composition that exhibits effectiveness by the method
JP5000196B2 (en) Evaluation method of whitening effect
JP2012245356A (en) Method for characterizing tone of skin and integument
EP3959651A1 (en) Apparatus and method for determining cosmetic skin attributes
Demirel et al. Influence of age, gender, and educational background on tooth color
JP4213429B2 (en) Screening method of inorganic powder composition effective for eliminating dull skin, inorganic powder composition thereof, and cosmetics using the composition
US11825928B2 (en) Method of recommending cosmetics based on melanin index and hemoglobin index and device thereof
JP5250956B2 (en) Evaluation method for elasticity
Egawa et al. Extended range near-infrared imaging of water and oil in facial skin
JP7307544B2 (en) Method for evaluating skin clarity
Hyttinen et al. Computational Filters for Dental and Oral Lesion Visualization in Spectral Images
Togawa et al. Clinical study on the comparison of dermoscopic images using two wavelengths of near‐ultraviolet‐visible light
Haq et al. Effects of different nail polish colors on arterial blood oxygen saturation values (spo2) in pakistani population
Lee et al. Development of a quantitative assessment method of pigmentary skin disease using ultraviolet optical imaging
JP2008094785A (en) Makeup method
Sun et al. Statistical characterization of face spectral reflectances and its application to human portraiture spectral estimation
JP7225749B2 (en) Notification device, notification method and program
JP6351550B2 (en) Harness feeling evaluation apparatus, firmness evaluation method, and firmness evaluation program
Ozawa et al. Improving the accuracy of noncontact blood pressure sensing using near-infrared light
JP5757149B2 (en) Skin evaluation method and skin evaluation system
JP2010159230A (en) Judging method of vividness of lip, powder composition and lip cosmetic
US11191341B2 (en) Notification device, notification method, and storage medium having program stored therein

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20090507

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20110930

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20111213

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120117

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20120515

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20120516

R150 Certificate of patent or registration of utility model

Ref document number: 5000196

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20150525

Year of fee payment: 3

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250